Efficacy of rectal indomethacin in prevention of post-operative hyperamylasemia following pancreatoduodenectomy: a randomized controlled trial
Langenbeck's Archives of Surgery · 2023
DOI: 10.1007/s00423-023-03212-9 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Langenbeck's Archives of Surgery, 2023. Verfasst von Anubhav Harshit Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery & Liver Transplant, Institute of Liver and Biliary Sciences, New Delhi, 110070, India. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Hyperamylasemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Post-operative hyperamylasemia (POH) following pancreatoduodenectomy (PD) may play a key role in pathogenesis of post-operative pancreatic fistula (POPF). Aim of the current study was to evaluate efficacy of perioperative administration of indomethacin in preventing POH. METHODS: Single-center, double-blind, randomized controlled trial (RCT) conducted on consecutive patients undergoing PD. Patients received either 100 mg of indomethacin per-rectally at induction of anesthesia or standard care. Primary endpoint was incidence of POH in the two arms. POH was defined as postoperative day (POD) 1 serum amylase (S. amylase) levels greater than the upper limit of normal. RESULTS: After exclusion 44 patients were randomized. The two arms were comparable for preoperative and intraoperative parameters. POH was noted in 20/44 (45.5%) with significantly lower incidence of POH (60.9% vs. 28.6%, p = 0.032) in intervention arm (IA). Median S. amylase, POD 1, 3, and 5 drain amylase, and incidence of clinically relevant POPF (CR-POPF) were lower in IA but failed to reach statistical significance (30.4% vs. 14.3%, p = 0.18). The severity of delayed gastric emptying (DGE) was significantly lower in the IA (grade B/C DGE 23.8% vs. 47.8%, p = 0.023). Evaluation of risk factors for POH showed IA to confer an independent protective effect and increased risk with soft pancreas. CONCLUSION: Perioperative per-rectal indomethacin administration is effective in decreasing the incidence of POH following pancreatoduodenectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery & Liver Transplant, Institute of Liver and Biliary Sciences, New Delhi, 110070, India.
- Department of Hepatopancreatobiliary Surgery & Liver Transplant, Institute of Liver and Biliary Sciences, New Delhi, 110070, India. viniyendra@yahoo.co.uk.
Zitieren
APA
Kumar, A. H., Pamecha, V., Patil, N. S., Mohapatra, N., Kilambi, R., & Sinha, P. K. (2023). Efficacy of rectal indomethacin in prevention of post-operative hyperamylasemia following pancreatoduodenectomy: a randomized controlled trial. Langenbeck's Archives of Surgery. https://doi.org/10.1007/s00423-023-03212-9
Vancouver
Kumar AH, Pamecha V, Patil NS, Mohapatra N, Kilambi R, Sinha PK. Efficacy of rectal indomethacin in prevention of post-operative hyperamylasemia following pancreatoduodenectomy: a randomized controlled trial. Langenbeck's Archives of Surgery. 2023. doi:10.1007/s00423-023-03212-9
BibTeX
@article{Kumar2023,
author = {Kumar, Anubhav Harshit and Pamecha, Viniyendra and Patil, Nilesh Sadashiv and Mohapatra, Nihar and Kilambi, Ragini and Sinha, Piyush Kumar},
title = {Efficacy of rectal indomethacin in prevention of post-operative hyperamylasemia following pancreatoduodenectomy: a randomized controlled trial},
journal = {Langenbeck's Archives of Surgery},
year = {2023},
doi = {10.1007/s00423-023-03212-9}
}
EUVIMED